Should BMW focus their R&D on developing new stereo systems?

There is a lot more riding on the success of an imaging trial today than ever before. The world economy, mergers and acquisitions, the state of sponsors’ pipelines and changes in the regulatory environment, have created the most demanding market for clinical trials ever. One of the results of this evolution is the increased focus […]

Read More...

The power of notifications in trials with image-based eligibility criteria

  We are seeing more and more imaging trial protocols requiring the analysis of subject eligibility to occur under tightening deadlines. Take for example a cardiovascular study using centralized analysis of an Intra-Vascular Ultrasound (IVUS) to determine whether a subject should be included in the trial. In this particular protocol, the patient remains in the […]

Read More...

Batching image submissions in clinical trials: the case against it!

Clinical trials are inherently risk management exercises, where sponsors, CROs and investigators work as a team to determine the effectiveness of a compound or treatment. In the late 1900s, form data submitted by investigators to CROs was sent using the latest in technology: fax. Prior to that, forms were mailed. The advent of EDC systems […]

Read More...

Cloud infrastructure in imaging trials: the need for quality

In an interesting interview in Bio.IT World, Glen DeVries, president of Medidata Solutions, spoke about the evolution of clinical trial processes and how we’re inevitably going toward cloud solutions. I couldn’t agree more. As Glen points out, we’ve seen this phenomenon across a multitude of industries: The advent of good software packages moved things from […]

Read More...